
BFKW, a US-based company, innovates in obesity treatment with the Full Sense™ Device, a temporary implant inducing significant weight loss, eliminating the need for invasive surgeries.
BFKW, founded in Grand Rapids, United States, focuses on revolutionizing obesity treatment through its innovative Full Sense™ Device. The company's core mission is to provide a non-invasive, temporary solution for significant weight loss, eliminating the need for traditional bariatric surgeries like gastric banding and bypass. The Full Sense™ Device, which is implanted and removed via endoscopy, induces long-lasting satiety by placing pressure on the esophagus and stomach, thereby reducing food intake.
BFKW has secured strong patent protection for the Full Sense™ Device in all its target markets. The company has garnered attention for its potential to transform obesity treatment, offering a less invasive alternative to current surgical options. While specific notable affiliated people and investors are not detailed, BFKW's key achievement lies in its innovative approach and the promising impact of its device on the healthcare industry.

Aspire Bariatrics

Buck Surgical
bucksurgical.com

Airway Innovations

Biophyx
biophyx.co

Biolectrics

FastWave Medical

Opus KSD
subq-it.com

Physiowave
physiowave.com

Bivacor
bivacor.com

S4 Medical
s4medical.com

OrthoFundamentals

Powers Medical Devices
powersmeddev.com

Boomerang Medical

IC Surgical
icsurgical.com

RevOrtho
revortho.com
Companies similar to Bfkw include Aspire Bariatrics, Buck Surgical, Airway Innovations and Biophyx.
Bfkw was founded in 2004.
Bfkw's headquarters is located in Grand Rapids, MI, US.
Bfkw's most recent funding round was for $10.3M (USD) in May 2017.
As of May 25, 2017, Bfkw has raised a total of $10.6M (USD).
Bfkw has 4 employees as of Feb 5, 2024.